BIM
AGIO icon

BlackRock Investment Management’s Agios Pharmaceuticals AGIO Stock Holding History

BlackRock Investment Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.07M Sell
25,623
-4,312
-14% -$226K ﹤0.01% 2661
2016
Q3 		$1.58M Buy
29,935
+6,759
+29% +$294K ﹤0.01% 2348
2016
Q2 		$971K Buy
23,176
+13,323
+135% +$658K ﹤0.01% 2664
2016
Q1 		$400K Sell
9,853
-2,714
-22% -$116K ﹤0.01% 2977
2015
Q4 		$816K Buy
12,567
+80
+0.6% +$5.25K ﹤0.01% 2737
2015
Q3 		$881K Sell
12,487
-1,881
-13% -$184K ﹤0.01% 2683
2015
Q2 		$1.6M Sell
14,368
-49,348
-77% -$5.32M ﹤0.01% 2413
2015
Q1 		$6.01M Buy
63,716
+1,006
+2% +$113K 0.01% 1251
2014
Q4 		$7.03M Buy
62,710
+7,771
+14% +$694K 0.01% 1159
2014
Q3 		$3.37M Buy
54,939
+9,225
+20% +$398K ﹤0.01% 1622
2014
Q2 		$2.1M Buy
45,714
+25,996
+132% +$1.06M ﹤0.01% 2044
2014
Q1 		$772K Buy
19,718
+860
+5% +$28.8K ﹤0.01% 2698
2013
Q4 		$452K Sell
18,858
-120
-0.6% -$2.73K ﹤0.01% 2998
2013
Q3 		$531K Buy
+18,978
New +$524K ﹤0.01% 2891

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Investment Management's AGIO Position: Q4 2016 in Review

BlackRock Investment Management reduced its Agios Pharmaceuticals (AGIO) stake by 14% in Q4 2016, selling an estimated $226K and leaving 25,623 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #2661.

BlackRock Investment Management first reported a position in AGIO in Q3 2013 and has held it in 14 quarters since. The position peaked at $7.03M in Q4 2014. 161 funds tracked by Wall St. Rank hold AGIO as of Q4 2016.

  • BlackRock Investment Management held 25,623 shares of Agios Pharmaceuticals worth $1.07M as of Q4 2016.
  • BlackRock Investment Management sold 4,312 Agios Pharmaceuticals shares in Q4 2016, an estimated $226K.
  • Agios Pharmaceuticals made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2661 holding.
  • BlackRock Investment Management first reported a position in Agios Pharmaceuticals in Q3 2013 and has held it in 14 quarters since.
  • BlackRock Investment Management's Agios Pharmaceuticals position peaked at $7.03M in Q4 2014.
  • 161 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.